The Department of Radiation Oncology at the University of Maryland is strongly committed to maintaining the quality of our educational program. Our department is at the forefront in innovation with its nationally recognized Medical Physics and Radiobiology divisions, which provide outstanding clinical and research experiences for trainees.
As clinical trainees, you will have the opportunity to train in the following facilities which include, but are not limited to:
- 4-D CT Capability
- Accelerated partial breast irradiation with SAVI, GammaPod, and 3DCRT
- Brachytherapy including:
- Gynecologic – HDR with interstitial capabilities
- Prostate – HDR and LDR
- Head and Neck – HDR
- Calypso 4D Localization System
- Deep and Superficial Thermal Therapy
- The Edge System
- Electron therapy
- Gamma Knife Treatment
- Image Guided Radiation Therapy (IGRT – CBCT, KV, Calypso, others)
- Intensity Modulated Arc Therapy (IMAT; RapidArc)
- Intensity Modulated Radiation Therapy (IMRT)
- PET-CT and MRI-CT fusion for target delineation
- Pencil beam scanning proton therapy
- Radioembolization, or Selective Internal Radiation Therapy (SIRT) for liver tumors
- Respiratory monitoring and management
- Spatially Fractionated (GRID) Therapy
- Stereotactic Body Radiation Therapy (SBRT)
- Stereotactic Radiosurgery (SRS)
- STx and brachytherapy
- Total Body Irradiation with translational couch
- Trilogy System
- Tumor Treating Fields
- Volumetric modulated arc therapy (VMAT)
The Varian ProBeam® Proton Therapy System at MPTC, one of the most advanced systems in the world
The Maryland Proton Treatment Center is the first and most experienced proton center in the region. Our center has trained more than 200 medical professionals on the use of proton therapy, including physicians from new and upcoming proton centers in the region.
With proton therapy at the Maryland Proton Treatment Center, patients have a new tool in the cancer-fighting toolbox. MPTC offers the most advanced form of proton therapy in the world – called pencil beam scanning. This technique is highly effective for a wide variety of solid, localized tumors in adults and children.
Since proton therapy delivers an increased dose that stops specifically at the tumor site, it protects much of the surrounding, normal tissue. It’s painless, non-invasive and well tolerated which often times leads to fewer side effects now and in the future.
The GammaPod at UMMC, located in the Gamma Knife Suite
GammaPod — the world's first radiation therapy system dedicated specifically to treat early-stage breast cancer — delivers a higher dose of radiation to the tumor and less radiation to nearby vital organs such as the heart and lungs. Using an approach called stereotactic body radiation therapy (SBRT), this innovative technology is also gentler on the skin and healthy breast tissue.
Doctors and scientists at the University of Maryland invented and developed GammaPod, which the U.S. Food and Drug Administration cleared for use in 2017. The University of Maryland Medical Center was the first in the world to use the new technology to treat patients, and is currently one of only two centers in the world to use GammaPod.
The only deep tissue thermal therapy unit in the world, located at the Maryland Proton Treatment Center (MPTC)
Thermal therapy is a non-invasive, non-toxic procedure that heats the tumor to between 104-110 degrees Fahrenheit and sensitizes cancer to other therapies. It is used in combination with protons, radiation, and chemotherapy. This treatment offers minimal side effects and when combined with other standard therapies can improve a patient’s odds of beating cancer.